Tech Company Financing Transactions

Magen BioSciences Funding Round

On 8/28/2006, Magen BioSciences received $15.4 million in Series A investment from Highland Capital Partners, Arch Venture Partners and Flybridge Capital Partners.

Transaction Overview

Company Name
Announced On
8/28/2006
Transaction Type
Venture Equity
Amount
$15,400,000
Round
Series A
Proceeds Purpose
Proceeds from this financing will be used to further develop and expand Magen's therapeutic programs and operations.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
100 Beaver Street 101
Waltham, MA 02453
USA
Email Address
Overview
Magen BioSciences is a specialty pharmaceutical company currently focused on developing proprietary medical therapies for the dermatology market.
Profile
Magen BioSciences LinkedIn Company Profile
Social Media
Magen BioSciences Company Twitter Account
Company News
Magen BioSciences News
Facebook
Magen BioSciences on Facebook
YouTube
Magen BioSciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Brian Gallagher
  Brian Gallagher LinkedIn Profile  Brian Gallagher Twitter Account  Brian Gallagher News  Brian Gallagher on Facebook
VP - Bus. Development
Cyrus Mozayeni
  Cyrus Mozayeni LinkedIn Profile  Cyrus Mozayeni Twitter Account  Cyrus Mozayeni News  Cyrus Mozayeni on Facebook
VP - R & D
Gordon Letts
  Gordon Letts LinkedIn Profile  Gordon Letts Twitter Account  Gordon Letts News  Gordon Letts on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/28/2006: PlayPhone venture capital transaction
Next: 8/28/2006: Trapeze Networks venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary